• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Deaconess Health Integrates Prescription Drug Monitoring Program With EHR

by Jasmine Pennic 07/26/2017 Leave a Comment

Deaconess Health Integrates Prescription Drug Monitoring Program With EHR

Deaconess Health System, network consisting of six hospitals in southwest Indiana has signed an agreement with Appriss Health to enable integration of prescription drug monitoring program (PDMP) directly into EHRs. The integration via Appriss Health’s PMP Gateway managed service solution enables access to data, analytics, tools and resources from PDMPs within care team workflows in real-time, at the point-of-care, at every patient encounter, to improve patient safety and outcomes. The EHR integration is the first of its kind in Indiana.

The PDMP-EHR integration will now allow clinicians the ability to access a patient’s prescription history within the EHR, whereas physicians and pharmacists previously needed to log into a separate INSPECT website to retrieve a patient’s controlled substance dispensations from the state database and then cross-reference that data with a patient’s health information in what was a time-consuming process.

PMP Gateway is a managed service platform that provides comprehensive connectivity, and access to clinical decision support, patient support, patient engagement and care coordination that interoperates seamlessly with leading EHR and pharmacy management systems, PMP InterConnect and 42 PDMPs across the U.S.

Deaconess Health System is also piloting Appriss Health’s NarxCare platform, which empowers prescribers and dispensers to identify patients that may be at risk for prescription drug addiction, overdose and death, and equips clinicians and care teams with the advanced analytics, tools and technology they need to help those patients.

“In the most recent statistics from the Indiana State Department of Health, we, unfortunately, saw opioid related deaths increase by 3.5 percent per year from 2011-2015. In addition, we saw a 60 percent increase in non-fatal ER visits from opioid overdose at the same time,” said Lieutenant Governor Suzanne Crouch in a statement. “This resource, putting INSPECT data directly in the hands of doctors making critical prescribing decisions, will save lives and support the State of Indiana in the fight against prescription drug and opioid abuse.”

 

Tagged With: EPCS, Prescription Drug Monitoring Program

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |